Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last?

Ann Surg Oncol. 2021 Apr;28(4):1884-1886. doi: 10.1245/s10434-020-09400-x. Epub 2021 Jan 16.

Authors

Jashodeep Datta¹, Nipun B Merchant²

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
² Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. [email protected].

PMID: 33454881
DOI: 10.1245/s10434-020-09400-x

No abstract available

Publication types

Editorial

MeSH terms

Combined Modality Therapy
Humans
Pancreatic Neoplasms* / surgery